Literature DB >> 28099406

Reducing the Threshold for Clinical Renal Xenotransplantation.

Peter J Cowan1, Francesco L Ierino.   

Abstract

Mesh：

Year:  2017        PMID： 28099406      PMCID： PMC7228590          DOI： 10.1097/TP.0000000000001641

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  8 in total

1.  Silencing porcine genes significantly reduces human-anti-pig cytotoxicity profiles: an alternative to direct complement regulation.

Authors:  James R Butler; Gregory R Martens; Jose L Estrada; Luz M Reyes; Joseph M Ladowski; Cesare Galli; Andrea Perota; Conor M Cunningham; Matthew Tector; A Joseph Tector
Journal:  Transgenic Res       Date:  2016-04-21       Impact factor: 2.788

2.  Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model.

Authors:  Laura Higginbotham; Dave Mathews; Cynthia A Breeden; Mingqing Song; Alton Brad Farris; Christian P Larsen; Mandy L Ford; Andrew J Lutz; Matthew Tector; Kenneth A Newell; A Joseph Tector; Andrew B Adams
Journal:  Xenotransplantation       Date:  2015-04-03       Impact factor: 3.907

3.  Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells From GGTA1/CMAH/B4GalNT2, and SLA Class I Knockout Pigs.

Authors:  Gregory R Martens; Luz M Reyes; Ping Li; James R Butler; Joseph M Ladowski; Jose L Estrada; Richard A Sidner; Devin E Eckhoff; Matt Tector; A Joseph Tector
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

4.  Investigation of potential carbohydrate antigen targets for human and baboon antibodies.

Authors:  Peter Yeh; Mohamed Ezzelarab; Nicolai Bovin; Hidetaka Hara; Cassandra Long; Koji Tomiyama; Frank Sun; David Ayares; Michel Awwad; David K C Cooper
Journal:  Xenotransplantation       Date:  2010 May-Jun       Impact factor: 3.907

5.  Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells.

Authors:  Marit Saethre; Bettina C Baumann; Michael Fung; Jörg D Seebach; Tom Eirik Mollnes
Journal:  Transplantation       Date:  2007-07-27       Impact factor: 4.939

6.  Genome-wide inactivation of porcine endogenous retroviruses (PERVs).

Authors:  Luhan Yang; Marc Güell; Dong Niu; Haydy George; Emal Lesha; Dennis Grishin; John Aach; Ellen Shrock; Weihong Xu; Jürgen Poci; Rebeca Cortazio; Robert A Wilkinson; Jay A Fishman; George Church
Journal:  Science       Date:  2015-10-11       Impact factor: 47.728

Review 7.  Kidney xenotransplantation.

Authors:  Peter J Cowan; David K C Cooper; Anthony J F d'Apice
Journal:  Kidney Int       Date:  2013-10-02       Impact factor: 10.612

8.  Cloning and expression of porcine β1,4 N-acetylgalactosaminyl transferase encoding a new xenoreactive antigen.

Authors:  Guerard W Byrne; Zeji Du; Paul Stalboerger; Heide Kogelberg; Christopher G A McGregor
Journal:  Xenotransplantation       Date:  2014-09-01       Impact factor: 3.907
  8 in total
  4 in total

Review 1.  Xenotransplantation: past, present, and future.

Authors:  Burcin Ekser; Ping Li; David K C Cooper
Journal:  Curr Opin Organ Transplant       Date:  2017-12       Impact factor: 2.640

2.  LIVER TRANSPLANTATION: WILL XENOTRANSPLANTATION BE THE ANSWER TO THE DONOR ORGAN SHORTAGE?

Authors:  Robert L Carithers
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

3.  Xenoantigen Deletion and Chemical Immunosuppression Can Prolong Renal Xenograft Survival.

Authors:  Andrew B Adams; Steven C Kim; Gregory R Martens; Joseph M Ladowski; Jose L Estrada; Luz M Reyes; Cindy Breeden; Allison Stephenson; Devin E Eckhoff; Matt Tector; Alfred Joseph Tector
Journal:  Ann Surg       Date:  2018-10       Impact factor: 12.969

4.  Anti-C5 Antibody Tesidolumab Reduces Early Antibody-mediated Rejection and Prolongs Survival in Renal Xenotransplantation.

Authors:  Andrew B Adams; Brendan P Lovasik; David A Faber; Christopher Burlak; Cynthia Breeden; Jose L Estrada; Luz M Reyes; Rodrigo M Vianna; Matthew F Tector; Alfred J Tector
Journal:  Ann Surg       Date:  2021-09-01       Impact factor: 13.787
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.